(Q53245275)

12 May 2018

title

Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas. (English)

1 reference

12 May 2018

author name string

Akinori Funayama

1

1 reference

12 May 2018

Jun Cheng

2

1 reference

12 May 2018

Satoshi Maruyama

3

1 reference

12 May 2018

Manabu Yamazaki

4

1 reference

12 May 2018

Takanori Kobayashi

5

1 reference

12 May 2018

Mei Syafriadi

6

1 reference

12 May 2018

Sukalyan Kundu

7

1 reference

12 May 2018

Susumu Shingaki

8

1 reference

12 May 2018

Chikara Saito

9

1 reference

12 May 2018

Takashi Saku

10

1 reference

12 May 2018

publication date

26 May 2011

1 reference

12 May 2018

published in

Pathobiology

1 reference

12 May 2018

volume

78

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

171-180

1 reference

12 May 2018

Histopathological varieties of oral carcinoma in situ: Diagnosis aided by immunohistochemistry dealing with the second basal cell layer as the proliferating center of oral mucosal epithelia

cites work

1 reference

Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias.

21 January 2018

1 reference

Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium

21 January 2018

1 reference

Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.

21 January 2018

1 reference

Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours

21 January 2018

1 reference

Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach

21 January 2018

1 reference

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

21 January 2018

1 reference

Lymphatic involvement in the histopathogenesis of mucous retention cyst.

21 January 2018

1 reference

Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors

21 January 2018

1 reference

Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation

21 January 2018

1 reference

Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas

21 January 2018

1 reference

Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy

21 January 2018

1 reference

Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells.

21 January 2018

1 reference

Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma.

21 January 2018

1 reference

Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis

21 January 2018

1 reference

Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.

21 January 2018

1 reference

Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000324926

1 reference

12 May 2018

1 reference

12 May 2018